Loading…

DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi's Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs

Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus that is the causative agent of primary effusion lymphoma and Kaposi's sarcoma. In healthy carriers, KSHV remains latent, but a compromised immune system can lead to lytic viral replication that increases the pr...

Full description

Saved in:
Bibliographic Details
Published in:Viruses 2022-09, Vol.14 (10), p.2083
Main Authors: Serfecz, Jacquelyn C, Hong, Yuan, Gay, Lauren A, Shekhar, Ritu, Turner, Peter C, Renne, Rolf
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c536t-7935345870dcdb2884dfc0766e4e7ca03b88ca2f59c55446634b0caa3e1110f23
cites cdi_FETCH-LOGICAL-c536t-7935345870dcdb2884dfc0766e4e7ca03b88ca2f59c55446634b0caa3e1110f23
container_end_page
container_issue 10
container_start_page 2083
container_title Viruses
container_volume 14
creator Serfecz, Jacquelyn C
Hong, Yuan
Gay, Lauren A
Shekhar, Ritu
Turner, Peter C
Renne, Rolf
description Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus that is the causative agent of primary effusion lymphoma and Kaposi's sarcoma. In healthy carriers, KSHV remains latent, but a compromised immune system can lead to lytic viral replication that increases the probability of tumorigenesis. RIG-I-like receptors (RLRs) are members of the DExD/H box helicase family of RNA binding proteins that recognize KSHV to stimulate the immune system and prevent reactivation from latency. To determine if other DExD/H box helicases can affect KSHV lytic reactivation, we performed a knock-down screen that revealed DHX29-dependent activities appear to support viral replication but, in contrast, DDX24 and DDX49 have antiviral activity. When DDX24 or DDX49 are overexpressed in BCBL-1 cells, transcription of all lytic viral genes and genome replication were significantly reduced. RNA immunoprecipitation of tagged DDX24 and DDX49 followed by next-generation sequencing revealed that the helicases bind to mostly immediate-early and early KSHV mRNAs. Transfection of expression plasmids of candidate KSHV transcripts, identified from RNA pull-down, demonstrated that KSHV mRNAs stimulate type I interferon (alpha/beta) production and affect the expression of multiple interferon-stimulated genes. Our findings reveal that host DExD/H box helicases DDX24 and DDX49 recognize gammaherpesvirus transcripts and convey an antiviral effect in the context of lytic reactivation.
doi_str_mv 10.3390/v14102083
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0108c7315df14428a554e0a6343207bb</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A746717835</galeid><doaj_id>oai_doaj_org_article_0108c7315df14428a554e0a6343207bb</doaj_id><sourcerecordid>A746717835</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-7935345870dcdb2884dfc0766e4e7ca03b88ca2f59c55446634b0caa3e1110f23</originalsourceid><addsrcrecordid>eNptkktvEzEQgFcIREvgwB9AljgAh7R-rR8XpNAUElGBVB7iZs16vYmr3XWwN6G988NxSAkNQj54NP7ms2Y0RfGU4BPGND7dEE4wxYrdK46J1nrMNSnv34mPikcpXWEshMbyYXHEBNVKcHpc_JyeX09PZ-hNuEYz13oLySU0nX6jHEFfbyOu0bxf-soP6NKBHfwGBh96FBr0HlYh-RcJfYJoQwdoklKwHgZXZ1tcubTxcZ1QdZMVg4vb6n6Bfvhhib76CC3qLj9M0uPiQQNtck9u71Hx5e3557PZ-OLju_nZ5GJsSyaGsdSsZLxUEte2rqhSvG4slkI47qQFzCqlLNCm1LYsOReC8QpbAOYIIbihbFTMd946wJVZRd9BvDEBvPmdCHFhIA7ets5ggpWVjJR1QzinCrLRYchKRrGsqux6vXOt1lXnauv6IfdzID186f3SLMLGaIG10CQLXt4KYvi-dmkwnU_WtS30LqyToZLqkkhKZEaf_4NehXXs86i2lCq55kz8pRaQG_B9E_K_dis1E8mFJFLl-Y2Kk_9Q-dSu8zb0rvE5f1DwaldgY0gpumbfI8Fmu35mv36ZfXZ3KHvyz76xX4s50Og</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2728549436</pqid></control><display><type>article</type><title>DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi's Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Serfecz, Jacquelyn C ; Hong, Yuan ; Gay, Lauren A ; Shekhar, Ritu ; Turner, Peter C ; Renne, Rolf</creator><creatorcontrib>Serfecz, Jacquelyn C ; Hong, Yuan ; Gay, Lauren A ; Shekhar, Ritu ; Turner, Peter C ; Renne, Rolf</creatorcontrib><description>Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus that is the causative agent of primary effusion lymphoma and Kaposi's sarcoma. In healthy carriers, KSHV remains latent, but a compromised immune system can lead to lytic viral replication that increases the probability of tumorigenesis. RIG-I-like receptors (RLRs) are members of the DExD/H box helicase family of RNA binding proteins that recognize KSHV to stimulate the immune system and prevent reactivation from latency. To determine if other DExD/H box helicases can affect KSHV lytic reactivation, we performed a knock-down screen that revealed DHX29-dependent activities appear to support viral replication but, in contrast, DDX24 and DDX49 have antiviral activity. When DDX24 or DDX49 are overexpressed in BCBL-1 cells, transcription of all lytic viral genes and genome replication were significantly reduced. RNA immunoprecipitation of tagged DDX24 and DDX49 followed by next-generation sequencing revealed that the helicases bind to mostly immediate-early and early KSHV mRNAs. Transfection of expression plasmids of candidate KSHV transcripts, identified from RNA pull-down, demonstrated that KSHV mRNAs stimulate type I interferon (alpha/beta) production and affect the expression of multiple interferon-stimulated genes. Our findings reveal that host DExD/H box helicases DDX24 and DDX49 recognize gammaherpesvirus transcripts and convey an antiviral effect in the context of lytic reactivation.</description><identifier>ISSN: 1999-4915</identifier><identifier>EISSN: 1999-4915</identifier><identifier>DOI: 10.3390/v14102083</identifier><identifier>PMID: 36298642</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Analysis ; Antiviral activity ; Antiviral Agents - metabolism ; Binding sites ; Care and treatment ; Cell culture ; Complications and side effects ; DEAD-box RNA Helicases - genetics ; DEAD-box RNA Helicases - metabolism ; deadbox helicases ; Diagnosis ; DNA helicase ; DNA Helicases - genetics ; Effusion ; Gene Expression Regulation, Viral ; Genomes ; Herpes ; Herpesvirus 8, Human - physiology ; Herpesvirus diseases ; HIV ; Human immunodeficiency virus ; Humans ; Immune system ; Immunoprecipitation ; Immunotherapy ; Infections ; innate immunity ; Interferon ; Interferon Type I - metabolism ; Kaposi's sarcoma ; Kaposis sarcoma ; KSHV ; Latency ; Lymphoma ; Messenger RNA ; Next-generation sequencing ; Patient outcomes ; pattern recognition receptor ; Plasmids ; Primary effusion lymphoma ; Proteins ; Replication ; Ribonucleic acid ; RNA ; RNA helicase ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; RNA-binding protein ; Sarcoma ; Sarcoma, Kaposi ; Transfection ; Tumorigenesis ; type I interferon ; Viral infections ; Virus Activation - genetics ; Virus Latency - genetics ; Virus Replication - genetics</subject><ispartof>Viruses, 2022-09, Vol.14 (10), p.2083</ispartof><rights>COPYRIGHT 2022 MDPI AG</rights><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-7935345870dcdb2884dfc0766e4e7ca03b88ca2f59c55446634b0caa3e1110f23</citedby><cites>FETCH-LOGICAL-c536t-7935345870dcdb2884dfc0766e4e7ca03b88ca2f59c55446634b0caa3e1110f23</cites><orcidid>0000-0001-5715-6717 ; 0000-0001-9901-0409 ; 0000-0001-7391-8806</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2728549436/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2728549436?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36298642$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Serfecz, Jacquelyn C</creatorcontrib><creatorcontrib>Hong, Yuan</creatorcontrib><creatorcontrib>Gay, Lauren A</creatorcontrib><creatorcontrib>Shekhar, Ritu</creatorcontrib><creatorcontrib>Turner, Peter C</creatorcontrib><creatorcontrib>Renne, Rolf</creatorcontrib><title>DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi's Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs</title><title>Viruses</title><addtitle>Viruses</addtitle><description>Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus that is the causative agent of primary effusion lymphoma and Kaposi's sarcoma. In healthy carriers, KSHV remains latent, but a compromised immune system can lead to lytic viral replication that increases the probability of tumorigenesis. RIG-I-like receptors (RLRs) are members of the DExD/H box helicase family of RNA binding proteins that recognize KSHV to stimulate the immune system and prevent reactivation from latency. To determine if other DExD/H box helicases can affect KSHV lytic reactivation, we performed a knock-down screen that revealed DHX29-dependent activities appear to support viral replication but, in contrast, DDX24 and DDX49 have antiviral activity. When DDX24 or DDX49 are overexpressed in BCBL-1 cells, transcription of all lytic viral genes and genome replication were significantly reduced. RNA immunoprecipitation of tagged DDX24 and DDX49 followed by next-generation sequencing revealed that the helicases bind to mostly immediate-early and early KSHV mRNAs. Transfection of expression plasmids of candidate KSHV transcripts, identified from RNA pull-down, demonstrated that KSHV mRNAs stimulate type I interferon (alpha/beta) production and affect the expression of multiple interferon-stimulated genes. Our findings reveal that host DExD/H box helicases DDX24 and DDX49 recognize gammaherpesvirus transcripts and convey an antiviral effect in the context of lytic reactivation.</description><subject>Analysis</subject><subject>Antiviral activity</subject><subject>Antiviral Agents - metabolism</subject><subject>Binding sites</subject><subject>Care and treatment</subject><subject>Cell culture</subject><subject>Complications and side effects</subject><subject>DEAD-box RNA Helicases - genetics</subject><subject>DEAD-box RNA Helicases - metabolism</subject><subject>deadbox helicases</subject><subject>Diagnosis</subject><subject>DNA helicase</subject><subject>DNA Helicases - genetics</subject><subject>Effusion</subject><subject>Gene Expression Regulation, Viral</subject><subject>Genomes</subject><subject>Herpes</subject><subject>Herpesvirus 8, Human - physiology</subject><subject>Herpesvirus diseases</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunoprecipitation</subject><subject>Immunotherapy</subject><subject>Infections</subject><subject>innate immunity</subject><subject>Interferon</subject><subject>Interferon Type I - metabolism</subject><subject>Kaposi's sarcoma</subject><subject>Kaposis sarcoma</subject><subject>KSHV</subject><subject>Latency</subject><subject>Lymphoma</subject><subject>Messenger RNA</subject><subject>Next-generation sequencing</subject><subject>Patient outcomes</subject><subject>pattern recognition receptor</subject><subject>Plasmids</subject><subject>Primary effusion lymphoma</subject><subject>Proteins</subject><subject>Replication</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA helicase</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA-binding protein</subject><subject>Sarcoma</subject><subject>Sarcoma, Kaposi</subject><subject>Transfection</subject><subject>Tumorigenesis</subject><subject>type I interferon</subject><subject>Viral infections</subject><subject>Virus Activation - genetics</subject><subject>Virus Latency - genetics</subject><subject>Virus Replication - genetics</subject><issn>1999-4915</issn><issn>1999-4915</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkktvEzEQgFcIREvgwB9AljgAh7R-rR8XpNAUElGBVB7iZs16vYmr3XWwN6G988NxSAkNQj54NP7ms2Y0RfGU4BPGND7dEE4wxYrdK46J1nrMNSnv34mPikcpXWEshMbyYXHEBNVKcHpc_JyeX09PZ-hNuEYz13oLySU0nX6jHEFfbyOu0bxf-soP6NKBHfwGBh96FBr0HlYh-RcJfYJoQwdoklKwHgZXZ1tcubTxcZ1QdZMVg4vb6n6Bfvhhib76CC3qLj9M0uPiQQNtck9u71Hx5e3557PZ-OLju_nZ5GJsSyaGsdSsZLxUEte2rqhSvG4slkI47qQFzCqlLNCm1LYsOReC8QpbAOYIIbihbFTMd946wJVZRd9BvDEBvPmdCHFhIA7ets5ggpWVjJR1QzinCrLRYchKRrGsqux6vXOt1lXnauv6IfdzID186f3SLMLGaIG10CQLXt4KYvi-dmkwnU_WtS30LqyToZLqkkhKZEaf_4NehXXs86i2lCq55kz8pRaQG_B9E_K_dis1E8mFJFLl-Y2Kk_9Q-dSu8zb0rvE5f1DwaldgY0gpumbfI8Fmu35mv36ZfXZ3KHvyz76xX4s50Og</recordid><startdate>20220920</startdate><enddate>20220920</enddate><creator>Serfecz, Jacquelyn C</creator><creator>Hong, Yuan</creator><creator>Gay, Lauren A</creator><creator>Shekhar, Ritu</creator><creator>Turner, Peter C</creator><creator>Renne, Rolf</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5715-6717</orcidid><orcidid>https://orcid.org/0000-0001-9901-0409</orcidid><orcidid>https://orcid.org/0000-0001-7391-8806</orcidid></search><sort><creationdate>20220920</creationdate><title>DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi's Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs</title><author>Serfecz, Jacquelyn C ; Hong, Yuan ; Gay, Lauren A ; Shekhar, Ritu ; Turner, Peter C ; Renne, Rolf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-7935345870dcdb2884dfc0766e4e7ca03b88ca2f59c55446634b0caa3e1110f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analysis</topic><topic>Antiviral activity</topic><topic>Antiviral Agents - metabolism</topic><topic>Binding sites</topic><topic>Care and treatment</topic><topic>Cell culture</topic><topic>Complications and side effects</topic><topic>DEAD-box RNA Helicases - genetics</topic><topic>DEAD-box RNA Helicases - metabolism</topic><topic>deadbox helicases</topic><topic>Diagnosis</topic><topic>DNA helicase</topic><topic>DNA Helicases - genetics</topic><topic>Effusion</topic><topic>Gene Expression Regulation, Viral</topic><topic>Genomes</topic><topic>Herpes</topic><topic>Herpesvirus 8, Human - physiology</topic><topic>Herpesvirus diseases</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunoprecipitation</topic><topic>Immunotherapy</topic><topic>Infections</topic><topic>innate immunity</topic><topic>Interferon</topic><topic>Interferon Type I - metabolism</topic><topic>Kaposi's sarcoma</topic><topic>Kaposis sarcoma</topic><topic>KSHV</topic><topic>Latency</topic><topic>Lymphoma</topic><topic>Messenger RNA</topic><topic>Next-generation sequencing</topic><topic>Patient outcomes</topic><topic>pattern recognition receptor</topic><topic>Plasmids</topic><topic>Primary effusion lymphoma</topic><topic>Proteins</topic><topic>Replication</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA helicase</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA-binding protein</topic><topic>Sarcoma</topic><topic>Sarcoma, Kaposi</topic><topic>Transfection</topic><topic>Tumorigenesis</topic><topic>type I interferon</topic><topic>Viral infections</topic><topic>Virus Activation - genetics</topic><topic>Virus Latency - genetics</topic><topic>Virus Replication - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serfecz, Jacquelyn C</creatorcontrib><creatorcontrib>Hong, Yuan</creatorcontrib><creatorcontrib>Gay, Lauren A</creatorcontrib><creatorcontrib>Shekhar, Ritu</creatorcontrib><creatorcontrib>Turner, Peter C</creatorcontrib><creatorcontrib>Renne, Rolf</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Databases</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ: Directory of Open Access Journals</collection><jtitle>Viruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serfecz, Jacquelyn C</au><au>Hong, Yuan</au><au>Gay, Lauren A</au><au>Shekhar, Ritu</au><au>Turner, Peter C</au><au>Renne, Rolf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi's Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs</atitle><jtitle>Viruses</jtitle><addtitle>Viruses</addtitle><date>2022-09-20</date><risdate>2022</risdate><volume>14</volume><issue>10</issue><spage>2083</spage><pages>2083-</pages><issn>1999-4915</issn><eissn>1999-4915</eissn><abstract>Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus that is the causative agent of primary effusion lymphoma and Kaposi's sarcoma. In healthy carriers, KSHV remains latent, but a compromised immune system can lead to lytic viral replication that increases the probability of tumorigenesis. RIG-I-like receptors (RLRs) are members of the DExD/H box helicase family of RNA binding proteins that recognize KSHV to stimulate the immune system and prevent reactivation from latency. To determine if other DExD/H box helicases can affect KSHV lytic reactivation, we performed a knock-down screen that revealed DHX29-dependent activities appear to support viral replication but, in contrast, DDX24 and DDX49 have antiviral activity. When DDX24 or DDX49 are overexpressed in BCBL-1 cells, transcription of all lytic viral genes and genome replication were significantly reduced. RNA immunoprecipitation of tagged DDX24 and DDX49 followed by next-generation sequencing revealed that the helicases bind to mostly immediate-early and early KSHV mRNAs. Transfection of expression plasmids of candidate KSHV transcripts, identified from RNA pull-down, demonstrated that KSHV mRNAs stimulate type I interferon (alpha/beta) production and affect the expression of multiple interferon-stimulated genes. Our findings reveal that host DExD/H box helicases DDX24 and DDX49 recognize gammaherpesvirus transcripts and convey an antiviral effect in the context of lytic reactivation.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36298642</pmid><doi>10.3390/v14102083</doi><orcidid>https://orcid.org/0000-0001-5715-6717</orcidid><orcidid>https://orcid.org/0000-0001-9901-0409</orcidid><orcidid>https://orcid.org/0000-0001-7391-8806</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1999-4915
ispartof Viruses, 2022-09, Vol.14 (10), p.2083
issn 1999-4915
1999-4915
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0108c7315df14428a554e0a6343207bb
source Publicly Available Content Database; PubMed Central
subjects Analysis
Antiviral activity
Antiviral Agents - metabolism
Binding sites
Care and treatment
Cell culture
Complications and side effects
DEAD-box RNA Helicases - genetics
DEAD-box RNA Helicases - metabolism
deadbox helicases
Diagnosis
DNA helicase
DNA Helicases - genetics
Effusion
Gene Expression Regulation, Viral
Genomes
Herpes
Herpesvirus 8, Human - physiology
Herpesvirus diseases
HIV
Human immunodeficiency virus
Humans
Immune system
Immunoprecipitation
Immunotherapy
Infections
innate immunity
Interferon
Interferon Type I - metabolism
Kaposi's sarcoma
Kaposis sarcoma
KSHV
Latency
Lymphoma
Messenger RNA
Next-generation sequencing
Patient outcomes
pattern recognition receptor
Plasmids
Primary effusion lymphoma
Proteins
Replication
Ribonucleic acid
RNA
RNA helicase
RNA, Messenger - genetics
RNA, Messenger - metabolism
RNA-binding protein
Sarcoma
Sarcoma, Kaposi
Transfection
Tumorigenesis
type I interferon
Viral infections
Virus Activation - genetics
Virus Latency - genetics
Virus Replication - genetics
title DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi's Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A28%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DExD/H%20Box%20Helicases%20DDX24%20and%20DDX49%20Inhibit%20Reactivation%20of%20Kaposi's%20Sarcoma%20Associated%20Herpesvirus%20by%20Interacting%20with%20Viral%20mRNAs&rft.jtitle=Viruses&rft.au=Serfecz,%20Jacquelyn%20C&rft.date=2022-09-20&rft.volume=14&rft.issue=10&rft.spage=2083&rft.pages=2083-&rft.issn=1999-4915&rft.eissn=1999-4915&rft_id=info:doi/10.3390/v14102083&rft_dat=%3Cgale_doaj_%3EA746717835%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c536t-7935345870dcdb2884dfc0766e4e7ca03b88ca2f59c55446634b0caa3e1110f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2728549436&rft_id=info:pmid/36298642&rft_galeid=A746717835&rfr_iscdi=true